{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:50:25Z","timestamp":1790297425721,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study aimed to explore the possible pathogenesis of a rare case of co-existing Cushing\u2019s syndrome (CS) and primary aldosteronism (PA) caused by bilateral adrenocortical adenomas secreting aldosterone and cortisol, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A 41-year-old Chinese woman with severe hypertension and hypokalemia for 5 and 2 years, respectively, was referred to our hospital. She had a Cushingoid appearance. Preoperative endocrinological examinations revealed autonomous cortisol and aldosterone secretion. Computed tomography revealed bilateral adrenal adenomas. Subsequently, adrenal vein sampling and sequential left and right partial adrenalectomy indicated the presence of a left aldosterone-producing tumor and a right cortisol-producing tumor. Pathological examination included immunohistochemical analysis of the resected specimens. Secretions of aldosterone and cortisol were observed both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. Further, whole-exome sequencing was performed for DNA that was extracted from peripheral blood leukocytes and bilateral adrenal adenomas in order to determine whether the patient had relevant variants associated with PA and CS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Immunohistochemical staining revealed that the left adenoma primarily comprised clear cells expressing CYP11B2, whereas the right adenoma comprised both eosinophilic compact and clear cells expressing CYP11B1. The mRNA levels of steroidogenic enzymes (including CYP11B1 and CYP17A1) were high in the right adenoma, whereas CYP11B2 was highly expressed in the left adenoma. A novel somatic heterozygous missense variant\u2014<jats:italic>KCNJ5<\/jats:italic> c.503T &amp;gt; G (p.L168R)\u2014was detected in the left adrenal adenoma, but no other causative variants associated with PA and CS were detected in the peripheral blood or right adrenocortical adenoma. In the primary cell culture of the resected hyperplastic adrenal adenomas, verapamil and nifedipine, which are two calcium channel blockers, markedly inhibited the secretion of both aldosterone and cortisol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We present an extremely rare case of bilateral adrenocortical adenomas with distinct secretion of aldosterone and cortisol. The heterogeneity of the tumor cell compositions of aldosterone- and cortisol-producing adenoma (A\/CPA) and somatic mutation of <jats:italic>KCNJ5<\/jats:italic> may have led to different hormone secretions in the bilateral adrenal adenomas.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1068335","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:14:21Z","timestamp":1678169661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Different cell compositions and a novel somatic KCNJ5 variant found in a patient with bilateral adrenocortical adenomas secreting aldosterone and cortisol"],"prefix":"10.3389","volume":"14","author":[{"given":"Liling","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies\u2013a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90883-X","article-title":"Concurrent hypercortisolism and hypermineralocorticoidism","volume":"62","author":"Hogan","year":"1977","journal-title":"Am J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical cushing's syndrome","volume":"58","author":"Hiraishi","year":"2011","journal-title":"Endocr J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4920841","DOI":"10.1155\/2018\/4920841","article-title":"Clinical characteristics of aldosterone- and cortisol-coproducing adrenal adenoma in primary aldosteronism","volume":"2018","author":"Tang","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03551.x","article-title":"High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas","volume":"71","author":"Piaditis","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"B8","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JME-17-0035","article-title":"Somatic and inherited mutations in primary aldosteronism","volume":"59","author":"Fernandes-Rosa","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal cushing's syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.02.007","article-title":"Genetics of cushing's syndrome","volume":"47","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocr J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1147-1375","article-title":"Identification of novel variants in MEN1: A study conducted with four multiple endocrine neoplasia type 1 patients","volume":"52","author":"Hu","year":"2020","journal-title":"Horm Metab Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1504","article-title":"A novel phenotype of familial hyperaldosteronism type III: Concurrence of aldosteronism and cushing's syndrome","volume":"101","author":"Tong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: The lost subtype of primary aldosteronism","volume":"164","author":"Sp\u00e4th","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: A Large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2169\/internalmedicine1962.30.26","article-title":"Primary aldosteronism with cortisol overproduction from bilateral multiple adrenal adenomas","volume":"30","author":"Nagae","year":"1991","journal-title":"Jpn J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-008-0064-3","article-title":"Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas","volume":"12","author":"Oki","year":"2008","journal-title":"Clin Exp Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1507\/endocrj.K08E-268","article-title":"Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: Report of a case","volume":"56","author":"Onoda","year":"2009","journal-title":"Endocr J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2010.35","article-title":"Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma","volume":"25","author":"Morimoto","year":"2011","journal-title":"J Hum Hypertens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2015.30.4.607","article-title":"Bilateral adrenocortical masses producing aldosterone and cortisol independently","volume":"30","author":"Lee","year":"2015","journal-title":"Endocrinol Metab (Seoul)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-019-0395-y","article-title":"Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1993.tb01686.x","article-title":"Cortisol production by aldosterone-producing adenomas in vitro","volume":"20","author":"Stowasser","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1240341","article-title":"An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells","volume":"124","author":"R\u00e1cz","year":"1990","journal-title":"J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3636","article-title":"A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3","volume":"100","author":"Monticone","year":"2015","journal-title":"4 residue. J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(05)70008-X","article-title":"Biochemical and ionic signaling mechanisms for ACTH-stimulated cortisol production","volume":"70","author":"Enyeart","year":"2005","journal-title":"Vitam Horm."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1068335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:14:24Z","timestamp":1678169664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1068335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":32,"alternative-id":["10.3389\/fendo.2023.1068335"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1068335","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1068335"}}